Johns Hopkins Team Develops Therapeutic, Nasally Delivered DNA Vaccine for Tuberculosis
On Apr. 1, 2026, a research team at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of…
-
-
Oragenics SARS-CoV-2 spike protein produced neutralizing antibodies with Intramuscular and intranasal adjuvants
On Aug. 30, 2021, Oragenics announced that the stabilized pre-fusion spike protein trimer produced by its Canadian collaborator…
